Vote Scores

Home / Companies / NOVONESIS A/S (NOVOZYMES A/S) / 3 Apr 2025

Meeting · year to 30 June 2025177 filers reporting

NOVONESIS A/S (NOVOZYMES A/S): meeting of 3 Apr 2025

Votes reported on Form N-PX, item by item

177 Form N-PX filers reported votes at the NOVONESIS A/S (NOVOZYMES A/S) meeting of 3 Apr 2025. Their records fall into 7 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

8 nominees; 83.6% of reported votes for; 84 filers withheld from or voted against at least one nominee.

2,104 vote records from 136 filers. 4 of the 126 filers that marked the item either way voted against management. 10 filers reported this item without a management mark.

88.2% for0.0% against11.8% other3.2% against management136 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

160 vote records from 77 filers. 3 of the 69 filers that marked the item either way voted against management. 8 filers reported this item without a management mark.

85.7% for3.9% against10.4% other4.3% against management77 filers99.1% for0.8% against0.1% other0.8% against management57,462,784 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

296 vote records from 136 filers. 0 of the 126 filers that marked the item either way voted against management. 10 filers reported this item without a management mark.

91.9% for0.0% against8.1% other0.0% against management136 filers99.9% for0.0% against0.1% other0.1% against management41,953,883 reported shares
4

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

1,038 vote records from 136 filers. 0 of the 126 filers that marked the item either way voted against management. 10 filers reported this item without a management mark.

91.9% for0.0% against8.1% other0.0% against management136 filers99.9% for0.0% against0.1% other0.0% against management135,716,962 reported shares, counted once per item in this group
5

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

459 vote records from 135 filers. 2 of the 128 filers that marked the item either way voted against management. 7 filers reported this item without a management mark.

93.3% for0.7% against5.9% other1.6% against management135 filers99.9% for0.0% against0.1% other0.0% against management61,651,599 reported shares, counted once per item in this group
6

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

623 vote records from 117 filers. 0 of the 108 filers that marked the item either way voted against management. 9 filers reported this item without a management mark.

87.2% for0.0% against12.8% other0.0% against management117 filers97.0% for0.0% against3.0% other0.0% against management66,825,348 reported shares, counted once per item in this group
7

OTHERIssuer

OTHER: management items

Management items in this category are shown together; filers word and number them differently.

213 vote records from 24 filers. 0 of the 20 filers that marked the item either way voted against management. 4 filers reported this item without a management mark.

83.3% for0.0% against16.7% other0.0% against management24 filers100.0% for0.0% against0.0% against management6,306,342 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForNo reportFor
DimensionalForNo reportFor
State Street and SPDRForNo reportFor
American CenturyForNo reportFor
Franklin TempletonForNo reportFor
InvescoForNo reportFor
EquitableForNo reportFor
Charles SchwabForNo reportFor
Nuveen and TIAAForNo reportFor
John Hancock and ManulifeForForFor
Morgan Stanley, Eaton Vance and CalvertAbstain or withhold *No reportFor
J.P. MorganForForFor
Goldman SachsForNo reportFor
WisdomTreeForNo reportFor
PGIM and PrudentialForNo reportFor
Jackson National fundsForForFor
Northern Trust and FlexSharesForForFor
SEIForNo reportFor
T. Rowe PriceForNo reportFor
ThriventForNo reportFor
Lincoln FinancialForForFor
VoyaForNo reportFor
First TrustForNo reportFor
Russell InvestmentsForNo reportFor
NationwideForNo reportFor
Victory CapitalForNo reportFor
Brighthouse FundsForForFor
Columbia ThreadneedleForNo reportFor
BNY MellonForNo reportFor
PrincipalForNo reportFor
Pacific Life fundsSplit or no voteNo reportSplit or no vote
MFSForNo reportFor
TransamericaForNo reportFor
AllianceBernsteinForNo reportFor
Hartford FundsForNo reportFor
PIMCOForNo reportFor
MassMutualNo reportForNo report
Neuberger BermanForNo reportFor
Artisan PartnersForNo reportFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the NOVONESIS A/S (NOVOZYMES A/S) meeting?

177 Form N-PX filers reported votes at the meeting of 3 Apr 2025. On say-on-pay, 3 of 69 voted against management (4.3%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by NOVONESIS A/S (NOVOZYMES A/S) on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for NOVONESIS A/S (NOVOZYMES A/S)

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing NOVONESIS A/S (NOVOZYMES A/S) with a meeting date within three days of 3 Apr 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.